That is according to the findings of a study presented on Friday at the European Academy of Neurology congress. The pilot ...

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Related Massive study looks at benefits, risks of GLP-1 weight-loss drugs GLP-1 medications show promise in slowing ... GLP-1 drug use rose from 0.1% of the population in 2018 to 0.4% in 2022.

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 ...

For this study, researchers analyzed U.S. federal research data in which people were asked about their GLP-1 prescriptions. Results showed that among people without diabetes, GLP-1 drug use rose ...

The rising use of glucagon-like peptide-1 (GLP ... of drug that mimics the glucagon-like peptide-1 hormone. It stimulates insulin secretion and reduces appetite, helping to control blood sugar and ...

Share on Pinterest Research is looking for ways to minimize muscle loss from GLP-1 drugs taken to treat ... said that “this study was helpful to show that some muscle can occur with significant ...

"This large cohort study represents a reassuring safety signal showing that GLP-1 drugs are not ... links between GLP-1 use and pancreatic cancer. And this just shows, as have other human studies ...